Literature DB >> 17096755

Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Benjamin Shneider1, Sukru Emre, Roberto Groszmann, John Karani, Patrick McKiernan, Shiv Sarin, Harohalli Shashidhar, Robert Squires, Riccardo Superina, Jean de Ville de Goyet, Roberto de Franchis.   

Abstract

Portal hypertension leads to a wide variety of complications, which lead to significant morbidity and mortality and are some of the leading reasons for liver transplantation in children with chronic liver disease. Evidence-based approaches to the management of adults with portal hypertension exist and have been comprehensively reviewed in a series of international meetings, including the Baveno meetings. Similar evidence-based approaches for the management of portal hypertension in children do not exist and as such international meetings on portal hypertension have not focused on this problem in children. On October 7, 2005 at The Mount Sinai School of Medicine, a panel of pediatric experts reviewed the most recent Baveno statement and crafted a statement modified with their opinions vis a vis approaches to the management of portal hypertension in children.

Entities:  

Mesh:

Year:  2006        PMID: 17096755     DOI: 10.1111/j.1399-3046.2006.00597.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  20 in total

Review 1.  Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.

Authors:  Arvind Srinath; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

2.  MDCT, MR and interventional radiology in biliary atresia candidates for liver transplantation.

Authors:  Roberto Miraglia; Settimo Caruso; Luigi Maruzzelli; Marco Spada; Silvia Riva; Marco Sciveres; Angelo Luca
Journal:  World J Radiol       Date:  2011-09-28

Review 3.  [Portosystemic shunt surgery between TIPS and liver transplantation].

Authors:  G Puhl; S Gül; P Neuhaus
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

4.  Perioperative strategies and thrombophilia in children with extrahepatic portal vein obstruction undergoing the meso-Rex bypass.

Authors:  Rukhmi Bhat; Timothy B Lautz; Riccardo A Superina; Robert Liem
Journal:  J Gastrointest Surg       Date:  2013-02-06       Impact factor: 3.452

Review 5.  Current management of primary sclerosing cholangitis in pediatric patients.

Authors:  Samar H Ibrahim; Keith D Lindor
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

Review 6.  Treatment of portal hypertension.

Authors:  Khurram Bari; Guadalupe Garcia-Tsao
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

Review 7.  Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.

Authors:  Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

Review 8.  Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

9.  Portal hypertension in children and young adults with biliary atresia.

Authors:  Benjamin L Shneider; Bob Abel; Barbara Haber; Saul J Karpen; John C Magee; Rene Romero; Kathleen Schwarz; Lee M Bass; Nanda Kerkar; Alexander G Miethke; Philip Rosenthal; Yumirle Turmelle; Patricia R Robuck; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

10.  Noninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertension.

Authors:  Marina Rossato Adami; Cristina Targa Ferreira; Carlos Oscar Kieling; Vania Hirakata; Sandra Maria Gonçalves Vieira
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.